Detroit, MI (PRWEB) June 22, 2010
Revenues grew for Ash Stevens, Inc. (ASI), a full-service cGMP contract manufacturer, by more than 50% in 2009--up from 25% revenue growth in 2008. ASI also posted the biggest revenue growth in Crain's Detroit Business's ranking of the largest Detroit-area biotech companies, rising from the 7th largest company in 2008 to the 5th in 2009.
Dr. Stephen A. Munk, president and CEO of ASI, attributed the success and sustained growth to the company's commitment to providing quality work, on time delivery, and attentive client service. With over 45 years of experience, the company has built strong brand recognition in the Life Science industry as a trusted partner and supplier of quality small-molecule drug development and cGMP manufacturing services. It is this commitment to quality, delivery, and client service that is fueling the current multi-year, multimillion dollar expansion at the company's manufacturing facility in Riverview Michigan that will allow the company to better meet the needs of its clients and create new jobs in the state of Michigan.
As further testament to ASI's dedication to quality pharmaceutical manufacturing in 2009, the Society of Chemical Manufacturers and Affiliates (SOCMA) honored Ash Stevens with two Silver Awards for commitment to performance improvements in Environmental, Health Safety and Security (EHS&S) practices. The awards are based on Ash Stevens achievements in meeting and exceeding compliance in two focus areas of SOCMA's ChemStewards® program: Planning and Operations as well as Employee Training and Engagement. The ChemStewards® program is uniquely designed to meet the specific needs for continuous improvement in EHS&S performance for the batch, custom, and specialty chemical industry.
"One of our key strengths beyond providing quality chemistry and on time delivery of active pharmaceutical ingredients is attentive client service. We strongly value our client partnerships--we share their same goals and establish interactive relationships to facilitate rapid communication and problem solving," said Dr. Munk. "We've seen our base of repeat clients grow this past year as evidence of our commitment to quality, on-time delivery, and client satisfaction."
About Ash Stevens, Inc.
Ash Stevens, Inc. (ASI) is a Contract Pharmaceutical Manufacturer founded in 1962. Headquartered in Detroit Michigan, ASI has extensive experience with the development and scale-up of commercial cancer APIs (Active Pharmaceutical Ingredients) and shares a longstanding and successful relationship with the National Cancer Institute. To date, ASI has 10 FDA approvals for drug substances that include manufacturing approvals for the active ingredients in Velcade®, Vidaza®, and Clolar®. The company has an excellent global regulatory compliance history and has been inspected by Ministries of Health from Japan, Korea, Mexico, Australia, European Union and the United States. Ash Stevens is a preferred contractor for the development and cGMP manufacture of innovator small molecule APIs for oncology indications. For more information, visit http://www.ashstevens.com.
# # #